Article
Cardiac & Cardiovascular Systems
Ekkehard Gruenig, Alison MacKenzie, Andrew J. Peacock, Christina A. Eichstaedt, Nicola Benjamin, Robert Nechwatal, Silvia Ulrich, Stephanie Saxer, Maurizio Bussotti, Marinella Sommaruga, Stefano Ghio, Lina Gumbiene, Egle Paleviciute, Elena Jureviciene, Antonio Cittadini, Anna A. Stanziola, Alberto M. Marra, Gabor Kovacs, Horst Olschewski, Joan-Albert Barbera, Isabel Blanco, Martijn A. Spruit, Frits M. E. Franssen, Anton Vonk Noordegraaf, Abilio Reis, Mario Santos, Sofia Goncalves Viamonte, Heleen Demeyer, Marion Delcroix, Eduardo Bossone, Martin Johnson
Summary: This study demonstrated that exercise training for patients with PAH and CTEPH can significantly improve quality of life, WHO functional class, and peak oxygen consumption, and is feasible, safe, and well-tolerated as an add-on to medical therapy.
EUROPEAN HEART JOURNAL
(2021)
Article
Cardiac & Cardiovascular Systems
Ekkehard Gruenig, Alison MacKenzie, Andrew J. Peacock, Christina A. Eichstaedt, Nicola Benjamin, Robert Nechwatal, Silvia Ulrich, Stephanie Saxer, Maurizio Bussotti, Marinella Sommaruga, Stefano Ghio, Lina Gumbiene, Egle Paleviciute, Elena Jureviciene, Antonio Cittadini, Anna A. Stanziola, Alberto M. Marra, Gabor Kovacs, Horst Olschewski, Joan-Albert Barbera, Isabel Blanco, Martijn A. Spruit, Frits M. E. Franssen, Anton Vonk Noordegraaf, Abilio Reis, Mario Santos, Sofia Goncalves Viamonte, Heleen Demeyer, Marion Delcroix, Eduardo Bossone, Martin Johnson
Summary: This study is the first multicentre and largest randomized, controlled study on the feasibility, safety, and efficacy of exercise training as add-on to medical therapy in PAH and CTEPH patients, showing that exercise training can improve patients' exercise capacity, quality of life, and WHO functional class.
EUROPEAN HEART JOURNAL
(2021)
Review
Medicine, General & Internal
Silvana Elena Hojda, Irina Camelia Chis, Simona Clichici
Summary: PAH is a severe medical condition that requires monitoring and treatment. Biomarkers play an important role in diagnosis, prognosis, and disease progression, providing valuable information through blood and urine tests.
Article
Cardiac & Cardiovascular Systems
Sophia Airhart, Nima Badie, Mark Doyle, Priscilla Correa-Jacque, Curt Daniels, Raymond Benza
Summary: PAH is a chronic, progressive disease that is incurable even with effective therapy. Targeting hemodynamic improvements to reduce the risk of subsequent RV failure is key to preserving long-term outcomes in PAH. Assessing RV adaptation to stress plays a pivotal role in guiding therapy for PAH patients.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
(2021)
Article
Cardiac & Cardiovascular Systems
Kevin Y. Chang, Katherine Giorgio, Katlin Schmitz, Rob F. Walker, Kurt W. Prins, Marc R. Pritzker, Stephen L. Archer, Pamela L. Lutsey, Thenappan Thenappan
Summary: This study examined the effects of chronic digoxin use on patients with pulmonary arterial hypertension (PAH) and found that digoxin use was associated with higher mortality and heart failure hospitalization rates.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Pharmacology & Pharmacy
Elisabetta Zampogna, Nicolino Ambrosino, Federico Mattia Oliva, Monica Rudi, Giovanni Sotgiu, Laura Saderi, Antonio Spanevello, Dina Visca
Summary: This study evaluated the impact of pulmonary rehabilitation on heart rate recovery (HRR) in individuals with asthma compared to those with COPD. The findings showed that individuals with asthma had a lower prevalence of slow HRR than those with COPD. However, exercise training significantly improved exercise capacity in both populations.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Cardiac & Cardiovascular Systems
Mattia Lunardi, Sijing Wu, Patrick W. Serruys, Yoshinobu Onuma, Osama Soliman, William Wijns, Wilfried Mullens, Faisal Sharif
Summary: More than half of heart failure patients also have pulmonary hypertension, which affects symptoms and prognosis. The role of exercise in this patient population is still unclear due to a lack of clear understanding of the relationship between exercise and changes in pulmonary artery pressure and symptoms. The limited evidence on this topic is contradictory and difficult to compare due to different exercise programs and assessment techniques. The different classes of heart failure further complicate the assessment of exercise effects on outcomes. Future studies using advanced technologies may provide more insights into the effects of exercise training in heart failure patients with pulmonary hypertension.
Review
Cardiac & Cardiovascular Systems
Audrey Borghi-Silva, Adriana S. Garcia-Araujo, Eliane Winkermann, Flavia R. Caruso, Daniela Bassi-Dibai, Cassia da Luz Goulart, Snehil Dixit, Guilherme Dionir Back, Renata G. Mendes
Summary: COPD and CHF are two prevalent comorbidities among the elderly population, with a higher prevalence of their coexistence due to common risk factors associated with the aging process. An integrated approach combining pharmacological optimization and non-pharmacological treatments has shown to be effective in improving the health status of COPD-CHF patients and reducing hospital admissions.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Lucas R. Celant, Jeroen N. Wessels, Azar Kianzad, J. Tim Marcus, Lilian J. Meijboom, Harm Jan Bogaard, Frances S. de Man, Anton Vonk Noordegraaf
Summary: This study aimed to investigate the relationship between reaching or maintaining a 45% threshold of right ventricular ejection fraction (RVEF) and treatment response, long-term functional stability, and prognosis in patients with pulmonary arterial hypertension (PAH). The findings demonstrated that patients who reached or maintained the 45% RVEF threshold had favorable prognosis and long-term stable RV function.
Article
Hematology
Amira Zawia, Nadine D. Arnold, Laura West, Josephine A. Pickworth, Helena Turton, James Iremonger, Adam T. Braithwaite, Jaime Canedo, Simon A. Johnston, A. A. Roger Thompson, Gaynor Miller, Allan Lawrie
Summary: The study showed that reducing CD68 macrophages globally affects the development of experimental PAH, particularly in male mice. Imbalance of macrophages can lead to changes in the PAH phenotype.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Hongyang Pi, Lu Xia, David D. Ralph, Samuel G. Rayner, Ali Shojaie, Peter J. Leary, Sina A. Gharib
Summary: In this study, metabolic profiling was used to identify the association between plasma metabolomic profiles and right ventricular dilation, mortality, and measures of disease severity in patients with pulmonary arterial hypertension (PAH). The polyamine, histidine, and sphingomyelin metabolic pathways were found to be associated with RV dilation, mortality, and disease severity.
CIRCULATION RESEARCH
(2023)
Article
Cardiac & Cardiovascular Systems
Shang Wang, Zi-Yan Guo, Xing-Xing Sun, Ping Yuan, Qin-Hua Zhao, Wen-Hui Wu, Hong-Ling Qiu, Ci-Jun Luo, Su-Gang Gong, Hui-Ting Li, Rui Zhang, Jing He, Lan Wang, Jin-Ming Liu, Jian Guo, Rong Jiang
Summary: The study explored the differences in exercise-induced venous-to-systemic shunt (EIS) in patients with IPAH and CTEPH. It was found that in IPAH patients, those with EIS had a better prognosis, with VO2/VE being an independent factor influencing EIS occurrence.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Karen S. W. Chia, Christine T. Shiner, Karen Brown, Cameron J. Holloway, Camila Moreyra, Nicole Bart, Peter K. K. Wong, Steven G. Faux, Eugene Kotlyar
Summary: This study examined the effects of outpatient exercise on hemodynamics and quality of life in patients with pulmonary arterial hypertension. The results suggest that outpatient exercise may improve hemodynamic function, quality of life, and muscular strength in these patients, although further research is needed.
PULMONARY CIRCULATION
(2022)
Article
Cardiac & Cardiovascular Systems
Derek Tran, Phillip Munoz, Edmund M. T. Lau, Jennifer A. Alison, Martin Brown, Yizhong Zheng, Patricia Corkery, Keith Wong, Steven Lindstrom, David S. Celermajer, Glen M. Davis, Rachael Cordina
Summary: Exercise intolerance is common in early stages of PAH and is associated with poorer prognosis. This study found that IMT can improve inspiratory muscle strength and 6-minute walk distance in PAH patients after 8 weeks.
HEART LUNG AND CIRCULATION
(2021)
Article
Cardiac & Cardiovascular Systems
Ze Ming Goh, Nithin Balasubramanian, Samer Alabed, Krit Dwivedi, Yousef Shahin, Alexander M. K. Rothman, Pankaj Garg, Allan Lawrie, David Capener, A. A. Roger Thompson, Faisal Alandejani, Jim M. Wild, Christopher S. Johns, Robert A. Lewis, Rebecca Gosling, Michael Sharkey, Robin Condliffe, David G. Kiely, Andrew J. Swift
Summary: This study investigated the prognostic value of patterns of right ventricular adaptation in patients with pulmonary arterial hypertension (PAH) using cardiac magnetic resonance imaging. The results showed that patients in different volume/mass groups had different survival outcomes, with those in the high-volume-low-mass group having a higher risk of treatment failure.
Article
Pharmacology & Pharmacy
Gusty Rizky Teguh Ryanto, Kennosuke Yorifuji, Koji Ikeda, Noriaki Emoto
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
(2020)
Article
Pharmacology & Pharmacy
Kennosuke Yorifuji, Yuko Uemura, Shinji Horibata, Goh Tsuji, Yoko Suzuki, Kazuhiko Nakayama, Takashi Hatae, Shunichi Kumagai, Noriaki Emoto
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
(2020)
Article
Cardiac & Cardiovascular Systems
Jun Mukai, Hidekazu Tanaka, Hiroyuki Sano, Shun Yokota, Makiko Suto, Hiroki Takada, Fumitaka Soga, Yutaka Hatani, Hiroki Matsuzoe, Keiko Hatazawa, Kensuke Matsumoto, Kazuhiko Nakayama, Noriaki Emoto, Ken-ichi Hirata
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
(2020)
Correction
Multidisciplinary Sciences
Agian Jeffilano Barinda, Koji Ikeda, Dhite Bayu Nugroho, Donytra Arby Wardhana, Naoto Sasaki, Sakiko Honda, Ryota Urata, Satoaki Matoba, Ken-Ichi Hirata, Noriaki Emoto
NATURE COMMUNICATIONS
(2020)
Editorial Material
Pharmacology & Pharmacy
Bambang Widyantoro, Gusty Rizky Teguh Ryanto, Noriaki Emoto
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
(2020)
Article
Multidisciplinary Sciences
Gusty R. T. Ryanto, Koji Ikeda, Kazuya Miyagawa, Ly Tu, Christophe Guignabert, Marc Humbert, Tomoyuki Fujiyama, Masashi Yanagisawa, Ken-ichi Hirata, Noriaki Emoto
Summary: The dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in endothelium plays a critical role in the progression of pulmonary arterial hypertension. Inhibin-beta -A/activin-A in endothelial cells could be a potential pharmacotherapeutic target for the treatment of pulmonary arterial hypertension.
NATURE COMMUNICATIONS
(2021)
Article
Biochemistry & Molecular Biology
Adam Prabata, Koji Ikeda, Elda Putri Rahardini, Ken-Ichi Hirata, Noriaki Emoto
Summary: The study demonstrates that GPNMB negatively regulates macrophage inflammatory capacities and ameliorates WAT inflammation in obesity, making it a promising therapeutic target for metabolic disorders associated with obesity.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2021)
Review
Biology
Andreas Haryono, Risa Ramadhiani, Gusty Rizky Teguh Ryanto, Noriaki Emoto
Summary: In this review, the basic functions of endothelin and related molecules, including their receptors and enzymes, are described. The important role of endothelin in cardiovascular diseases is discussed, along with the clinical evidence for targeting the endothelin pathway and the future scope of endothelin-targeting treatments. The current uses of endothelin receptor antagonists and advancements in treatment options are highlighted, providing an overview of endothelin research over the years and its potential future developments.
Article
Pharmacology & Pharmacy
Ratih Paramita Suprapto, Yoko Suzuki, Tatsuya Nagano, Ken-Ichi Hirata, Noriaki Emoto
Summary: Lung adenocarcinoma, the leading cause of cancer-related deaths worldwide, was found to have increased expression of endothelin-2 (ET-2) which was associated with poor overall survival. Silencing ET-2 inhibited proliferation, migration, and invasion, and enhanced apoptosis in lung adenocarcinoma cells.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
(2022)
Article
Biology
Keisuke Miwa, Yu Taniguchi, Hiroyuki Fujii, Yoichiro Matsuoka, Hiroyuki Onishi, Kenichi Yanaka, Yu Izawa, Yasunori Tsuboi, Atsushi Kono, Noriaki Emoto, Kenichi Hirata
Summary: Poor subpleural perfusion (PSP) on dual-energy computed tomography (DE-CT) is a specific imaging finding in chronic thromboembolic pulmonary hypertension (CTEPH) and suggests a different mechanism of microvasculopathy from that in pulmonary arterial hypertension (PAH).
Article
Neurosciences
Shoji Kawauchi, Taiji Mizoguchi, Sayo Horibe, Toru Tanaka, Naoto Sasaki, Koji Ikeda, Noriaki Emoto, Ken-ichi Hirata, Yoshiyuki Rikitake
Summary: This study investigated the effects of aging-related changes on the neurovascular unit (NVU). It was found that senescence in the vascular endothelial cells led to morphological alterations in astrocytes and affected the localization of the water channel AQP4 at the gliovascular interface.
Article
Cardiac & Cardiovascular Systems
Hiroyuki Fujii, Yu Taniguchi, Sachiyo Yoneda, Keisuke Miwa, Yoichiro Matsuoka, Kenichi Yanaka, Yasunori Tsuboi, Noriaki Emoto, Kenichi Hirata
Summary: In this study, data from 149 patients with chronic thromboembolic pulmonary hypertension (CTEPH) were analyzed. The results showed that the efficacy and safety of balloon pulmonary angioplasty (BPA) for CTEPH with concurrent chronic obstructive pulmonary disease (COPD) were similar to those without COPD. Oxygenation and forced expiratory volume in 1 second/forced vital capacity showed improvement in patients with COPD. Therefore, BPA should be considered as a treatment option for CTEPH patients with concurrent COPD.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Review
Biochemistry & Molecular Biology
Gusty Rizky Teguh Ryanto, Ahmad Musthafa, Tetsuya Hara, Noriaki Emoto
Summary: Advances in technology and biomedical knowledge have improved the diagnosis and treatment of rare diseases, including pulmonary arterial hypertension (PAH). This article explores the role of activins and inhibins in PAH development and their connection to signaling pathways implicated in the pathogenesis of PAH. It also discusses the potential therapeutic benefits of activin/inhibin-targeting drugs, such as sotatercep, in improving patient outcomes. Overall, this article highlights the importance of activin/inhibin signaling as a critical mediator in PAH development and its potential as a target for future treatment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Neurosciences
Sayo Horibe, Takuo Emoto, Taiji Mizoguchi, Toru Tanaka, Shoji Kawauchi, Naoto Sasaki, Tomoya Yamashita, Koji Ikeda, Noriaki Emoto, Ken-ichi Hirata, Yoshiyuki Rikitake
Summary: Alzheimer's disease is a common neurodegenerative disease associated with aging. Endothelial cell senescence has been found in the brains of Alzheimer's disease patients, but its role in the pathogenesis of the disease is unclear. The study revealed that endothelial cell senescence alters microglial morphology and function, providing a potential clue for the prevention and treatment of Alzheimer's disease.
Article
Cardiac & Cardiovascular Systems
Muhammad R. Hadwiono, Anggoro B. Hartopo, Widya Wasityastuti, Dyah W. Anggrahini, Gusty R. T. Ryanto, Noriaki Emoto, Lucia K. Dinarti
Summary: This study found that Activin A may have a role in the development and progression of pulmonary artery hypertension (PAH) caused by uncorrected congenital heart disease (CHD-PAH). Serum levels of Activin A were significantly increased in subjects with uncorrected CHD, and were even more significantly elevated in CHD-PAH patients compared to controls. Therefore, the measurement of serum Activin A shows promise in identifying uncorrected CHD patients with PAH development and progression.
PULMONARY CIRCULATION
(2023)